Fig. 1From: Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trialStudy enrollment and baseline TB screening. Legend: (+) test-positive; (-) test-negative. Urine LAM-positive participants with risk factors for drug-resistant TB (prior TB treatment, contact with drug-resistant TB case) will undergo sputum Xpert Ultra testing for rapid detection of rifampin-resistance. All participants who test positive for TB (including urine LAM-positive/sputum Xpert Ultra-negative participants) will be referred to routine clinicians for TB treatment initiationBack to article page